speb/financial-data huggingface dataset:
PVRINOX.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 12610000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Other Payable: 2243000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Other Properties: 85973000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 1703000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 296000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Other Special Charges: -11000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Payables: 8755000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 938000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Pretax Income: -439000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -38000000.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -161000000.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -6344000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 261000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 20990000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 12193000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 948000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 948000000.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -14777000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -14585000000.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 147000000.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 75000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 543000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1595000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Share Issued: 98134446.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 10295000000.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -10432000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Special Income Charges: -155000000.00
PVRINOX.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 55000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 73235000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 14427000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 9435000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Tax Provision: -112000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
PVRINOX.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: 326000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Total Assets: 168204000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 83709000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Total Debt: 83035000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 73232000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Total Expenses: 54839000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 94972000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 158265000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 71469000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 251000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 37000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 37000000.00
PVRINOX.NS balance_sheet (annual, 2024-03-31) — Working Capital: -13564000000.00
PVRINOX.NS income_statement (annual, 2024-03-31) — Write Off: 166000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 6049000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1799000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 4192000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 66087000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 982000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 4945000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 6296000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 982000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 71381000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 943000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 11058000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 5929000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 6618000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 12547000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 24842000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 458000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 57431000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 58738000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 86686000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 824000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 88594000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 147000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 4192000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Investmentsin Joint Venturesat Cost: 0.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 60158000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 10595000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 70753000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 0.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 162000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 20000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 12268000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 86686000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 12643000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 5536000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 26000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 98193296.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 2122000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 4573000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 70399000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 1307000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 904000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 120000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 85743000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 17000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1351000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Payables: 6049000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 98193296.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 71381000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 12643000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 168522000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 81976000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 83300000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 71401000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 97121000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 157464000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 72279000000.00
PVRINOX.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -13784000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 8909000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 17173000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 98087432.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 3.66
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 6188000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 3201000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 3201000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 98087432.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 3.66
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 359000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — EBIT: 2493000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — EBITDA: 5694000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 10985000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 2031000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 2031000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 4000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Income: 359000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 359000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 355000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 359000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 359000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 355000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -2031000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -2031000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 5694000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 359000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Operating Income: 2076000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 17173000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 418000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 3968000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 462000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 6188000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 3201000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 107000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.23
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 15097000000.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
PVRINOX.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PVRINOX.NS income_statement (annual, 2025-03-31) — +Operating Expense: 34790000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 8546000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — +Total Revenue: 56999000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 12299000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 7523000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 7523000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2430000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2430000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -46146000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -46146000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 86176000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 86176000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -416000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -416000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Amortization: 231000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 231000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 97000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 97000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 98174157.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 98193244.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Basic EPS: -28.48
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -12.73
PVRINOX.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 3930000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 96365000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 96365000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -3307000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 62838000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 62838000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 982000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 982000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5225000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5225000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5288000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5288000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 1545000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1545000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 3680000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 3680000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -19000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Change In Payable: 3166000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 381000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 3543000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 1295000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Common Stock: 982000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 982000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 70515000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 70515000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 32000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1183000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1183000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 19410000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 4014000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Current Assets: 10810000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 10810000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 6499000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6499000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Current Debt: 5710000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 5710000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 12209000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 12209000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 24977000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 24977000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 381000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 381000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Depreciation: 12774000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 12774000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 12774000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 3155000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 12774000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 3155000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 98174157.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 98193244.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Diluted EPS: -28.48
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -12.73
PVRINOX.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -2796000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1250000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — EBIT: 4485000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — EBIT: 323000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — EBITDA: 17259000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — EBITDA: 3478000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — End Cash Position: 5225000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -15348000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 593000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 593000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 16368000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -5000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 6000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1036000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Goodwill: 57431000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 57431000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 58687000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 58687000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2846000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2846000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 127559000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 127559000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Gross Profit: 37589000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 8285000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Interest Expense: 8067000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 1955000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 8067000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1955000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Interest Income: 437000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 437000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1837000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 71000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Inventory: 802000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 802000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 85423000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 85423000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3032000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 145000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 145000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 97000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 97000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 12000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 12000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 32000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 9416000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1386000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1386000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 56339000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 56339000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 9198000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 9198000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 65537000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 65537000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 2950000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -4631000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 12000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 12000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 153000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 153000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 28625000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 28625000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 19000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 19000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Minority Interests: 13000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 3000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -15000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 32000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Net Debt: 9683000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 9683000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -5000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Income: -2796000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Income: -1250000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -2796000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1250000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -2648000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1208000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: -161000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -45000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2796000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1250000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2635000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1205000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -3582000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -2809000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1253000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Interest Income: -8067000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -1955000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 189000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -2281000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -1681000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -8067000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1955000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -19000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -62000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Net PPE: 81413000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 81413000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -3215000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -600000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 11828000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 11828000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Non Current Accrued Expenses: 0.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 0.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 82000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 82000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 5894000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 5894000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 12000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 12000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 4908000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 4908000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 17259000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3478000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Normalized Income: -2635000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -1205000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 19675000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Operating Income: 2799000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Operating Income: -261000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Operating Revenue: 56999000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 12299000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 98199962.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 98199962.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 2067000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2067000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1871000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1871000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 268000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 268000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1256000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1256000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 6731000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 772000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 772000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 82000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 82000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1709000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 586000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 15476000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3776000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Payable: 3831000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 3831000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Properties: 80230000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 80230000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1394000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1394000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 63000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 63000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Other Special Charges: 6000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Payables: 11355000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Payables: 11355000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 895000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 895000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Pretax Income: -3582000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -1632000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -19000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -15000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -30000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -3307000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 209000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 209000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 19410000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4014000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 12774000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3155000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 718000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 718000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -11697000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -17383000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -17383000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 189000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 92000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 592000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1628000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Share Issued: 98199962.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 98199962.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 6466000000.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -7066000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
PVRINOX.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 1000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 70515000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 70515000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 11828000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 11828000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Tax Provision: -934000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -424000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
PVRINOX.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 441000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Total Assets: 162624000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 162624000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 79713000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 79713000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Total Debt: 77746000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 77746000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 70534000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 70534000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Total Expenses: 54200000000.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 12560000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 92090000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 92090000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 151814000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 151814000000.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 67113000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 67113000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 212000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
PVRINOX.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
PVRINOX.NS balance_sheet (annual, 2025-03-31) — Working Capital: -14167000000.00
PVRINOX.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -14167000000.00
PVRINOX.NS income_statement (annual, 2025-03-31) — Write Off: 55000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 8520000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 14496000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 98003630.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -5.51
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 5016000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 3077000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 3077000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 98003630.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -5.51
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -540000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — EBIT: 1280000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — EBITDA: 4357000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 9480000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 1912000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1912000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 5000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Income: -540000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -540000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -474000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -71000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -540000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -469000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -545000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -1912000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1912000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 4357000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -469000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Operating Income: 960000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 14496000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 321000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3817000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -632000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 5016000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3077000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -158000000.00
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
PVRINOX.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 13536000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 9295000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 18798000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 98153846.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 9.75
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6452000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 3172000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 3172000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 98659794.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 9.70
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 957000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — EBIT: 3002000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — EBITDA: 6174000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 12346000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1809000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1809000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 3000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Income: 957000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 957000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 954000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 957000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 957000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 954000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1809000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1809000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 6620000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 1313650461.02
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Operating Income: 3051000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 18798000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 398000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 4201000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 446000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 1193000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6452000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3172000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -446000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -89349538.98
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 239000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 15747000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -446000000.00
PVRINOX.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -446000000.00
PVRINOX.NS income_statement (annual, 2026-03-31) — +Operating Expense: 35755000000.00
PVRINOX.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 9048000000.00
PVRINOX.NS income_statement (annual, 2026-03-31) — +Total Revenue: 66462000000.00
PVRINOX.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 15473000000.00
PVRINOX.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 5948000000.00
PVRINOX.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5948000000.00
PVRINOX.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2672000000.00
PVRINOX.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2672000000.00
PVRINOX.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 4238000000.00
PVRINOX.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 4238000000.00
PVRINOX.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 98235813.00
PVRINOX.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 98314903.00
PVRINOX.NS income_statement (annual, 2026-03-31) — Basic EPS: 34.01
PVRINOX.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 18.99
PVRINOX.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 5225000000.00
PVRINOX.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -2587000000.00
PVRINOX.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 60205000000.00
PVRINOX.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 60205000000.00
PVRINOX.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 982000000.00
PVRINOX.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 982000000.00
PVRINOX.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 5883000000.00
PVRINOX.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5883000000.00
PVRINOX.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6009000000.00
PVRINOX.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6009000000.00
PVRINOX.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -66000000.00
PVRINOX.NS cash_flow (annual, 2026-03-31) — Change In Payable: 237000000.00
PVRINOX.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -68000000.00
PVRINOX.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 238000000.00